Abstract
Chronic rhinosinusitis (CRS) is believed to be the result of an exaggerated reaction to fungi in the nasal mucosa, and topical amphotericin B (AMB) is a commonly used treatment. The purpose of this study was to perform a meta-analysis of high-quality comparative studies to examine the efficacy of topical AMB for the treatment of CRS. A search was conducted of Medline, Cochrane, EMBASE, and ISI Web of Knowledge until December 31, 2013 using combinations of the search terms chronic rhinosinusitis, human, treatment, antibiotics, nasal irrigation, nebulized, nasal lavage, sinonasal rinses, and antimicrobials. Inclusion criteria were (1) comparative studies, (2) a diagnosis of CRS or chronic sinusitis, and (3) the intervention was a topical antifungal. The primary outcome measure was quality of life (QOL), and the secondary was nasal endoscopy score. Of 235 article initially identified, five randomized controlled trials were included in the meta-analysis. Analysis of four studies with complete QOL data found no difference between treatment and placebo groups [standard difference in means 0.78, 95 % confidence interval (CI) −0.25 to 1.81, P = 0.138]. Analysis of four studies with complete nasal endoscopy score data found no difference between the treatment and placebo groups (standard difference in means 0.34, 95 % CI −0.08 to 0.76, P = 0.117). AMB is not more effective than placebo in improving QOL or nasal endoscopy scores in patients with CRS.
Similar content being viewed by others
References
Van Cauwenberge P, Watelet JB (2000) Epidemiology of chronic rhinosinusitis. Thorax 55:S20–S21
Hastan D, Fokkens WJ, Bachert C, Newson RB, Bislimovska J et al (2011) Chronic rhinosinusitis in Europe: an underestimated disease. A GA(2)LEN study. Allergy 66:1216–1223
Wang PC, Tai CJ, Lin MS, Chu CC, Liang SC (2003) Quality of life in Taiwanese adults with chronic rhino-sinusitis. Qual Life Res 12:443–448
Fokkens W, Lund V, Mullol J, European Position Paper on Rhinosinusitis and Nasal Polyps group (2007) European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 20:1–136
Rank MA, Adolphson CR, Kita H (2009) Antifungal therapy for chronic rhinosinusitis: the controversy persists. Curr Opin Allergy Clin Immunol 9:67–72
Piromchai P, Kasemsiri P, Laohasiriwong S, Thanaviratananich S (2013) Chronic rhinosinusitis and emerging treatment options. Int J Gen Med 6:453–464
Ponikau JU, Sherris DA, Kern EB, Homburger HA, Frigas E et al (1999) The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 74:877–884
Braun H, Buzina W, Freudenschuss K, Beham A, Stammberger H (2003) “Eosinophilic fungal rhinosinusitis”: a common disorder in Europe? Laryngoscope 113:264–269
Manes RP, Batra PS (2013) Etiology, diagnosis and management of chronic rhinosinusitis. Expert Rev Anti Infect Ther 11:25–35
Ponikau JU, Sherris DA, Weaver A, Kita H (2005) Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol 115:125–131
Ebbens FA, Scadding GK, Badia L, Hellings PW, Jorissen M et al (2006) Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol 118:1149–1156
Weschta M, Rimek D, Formanek M, Polzehl D, Podbielski A et al (2004) Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol 113:1122–1128
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151:W65–W94
Higgins JP, Green S eds (2001) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available at: www.cochrane-handbook.org
Sutton AJ, Duval SJ, Tweedie RL, Abrams KR, Jones DR (2000) Empirical assessment of effect of publication bias on meta-analyses. BMJ 320:1574–1577
Gerlinger I, Fittler A, Fónai F, Patzkó A, Mayer A et al (2009) Postoperative application of amphotericin B nasal spray in chronic rhinosinusitis with nasal polyposis, with a review of the antifungal therapy. Eur Arch Otorhinolaryngol 266:847–855
Liang KL, Su MC, Shiao JY, Tseng HC, Hsin CH et al (2008) Amphotericin B irrigation for the treatment of chronic rhinosinusitis without nasal polyps: a randomized, placebo-controlled, double-blind study. Am J Rhinol 22:52–58
Kennedy JL, Borish L (2013) Chronic rhinosinusitis and antibiotics: the good, the bad, and the ugly. Am J Rhinol Allergy 27:467–472
Helms S, Miller AL (2006) Natural treatment of chronic rhinosinusitis. Altern Med Rev 11:196–207
Snidvongs K, Kalish L, Sacks R, Craig JC, Harvey RJ (2011) Topical steroid for chronic rhinosinusitis without polyps. Cochrane Database Syst Rev 8:CD009274
Pynnonen MA, Venkatraman G, Davis GE (2013) Macrolide therapy for chronic rhinosinusitis: a meta-analysis. Otolaryngol Head Neck Surg 148:366–373
Wei CC, Adappa ND, Cohen NA (2013) Use of topical nasal therapies in the management of chronic rhinosinusitis. Laryngoscope 123:2347–2359
Jervis-Bardy J, Boase S, Psaltis A, Foreman A, Wormald PJ (2012) A randomized trial of mupirocin sinonasal rinses versus saline in surgically recalcitrant Staphylococcal chronic rhinosinusitis. Laryngoscope 122:2148–2153
Videler WJ, Drunen CM, Reitsma JB, Fokkens WJ (2008) Nebulized bacitracin/colimycin: a treatment option in recalcitrant chronic rhinosinusitis with staphylococcus auresus? A double blind, randomized, placebo-controlled, cross-over pilot study. Rhinology 46:92–98
Desrosiers MY, Salas-Prato M (2001) Treatment of chronic rhonosinusitis refractory to other treatments with topical antibiotic therapy delivered by means of a large-particle nebulizer: results of a controlled trial. Otolaryngol Head Neck Surg 125:265–269
Weschta M, Rimek D, Formanek M, Podbielski A, Riechelmann H (2006) Effect of nasal antifungal therapy on nasal cell activation markers in chronic rhinosinusitis. Arch Otoloaryngol Head Neck Surg 132:743–747
Ebbens FA, Georgalas C, Luiten S, van Drunen CM, Badia AL et al (2009) The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a multicenter randomized controlled study. Laryngoscope 119:401–408
Isaacs S, Fakhri S, Luong AM, Citardi MJ (2011) A meta-analysis of topical amphotericin B for the treatment of chronic rhinosinusitis. Int Forum Allergy Rhinol 1:250–254
Sacks PL 4th, Harvey RJ, Rimmer J, Gallagher RM, Sacks R (2012) Antifungal therapy in the treatment of chronic rhinosinusitis: a meta-analysis. Am J Rhinol Allergy 26:141–147
Fokkens WJ, van Drunen C, Georgalas C, Ebbens F (2012) Role of fungi in pathogenesis of chronic rhinosinusitis: the hypothesis rejected. Curr Opin Otolaryngol Head Neck Surg 20:19–23
Mistry SG, Kumar BN (2014) The value of antifungal therapy in allergic fungal rhinosinusitis. Rhinology 52:9–18
Kennedy DW, Kuhn FA, Hamilos DL, Zinreich SJ, Butler D et al (2005) Treatment of chronic rhinosinusitis with high-dose oral terbinafine: a double blind, placebo-controlled study. Laryngoscope 115:1793–1799
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, T., Su, J. & Feng, Y. The effectiveness topical amphotericin B in the management of chronic rhinosinusitis: a meta-analysis. Eur Arch Otorhinolaryngol 272, 1923–1929 (2015). https://doi.org/10.1007/s00405-014-3269-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-014-3269-y